Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Diabetic Kidney Disease Clinical Trials
Diabetic Kidney Disease clinical trials are recruiting across 32 cities. Here are the cities with the most active studies:
Diabetic Kidney Disease Trial Phases
7 research organizations are sponsoring diabetic kidney disease trials.
About Diabetic Kidney Disease
Diabetic kidney disease (diabetic nephropathy) is a complication of diabetes that affects the kidneys' filtering ability, potentially leading to kidney failure. It is the leading cause of end-stage kidney disease worldwide. Management includes blood sugar control, blood pressure medications, and SGLT2 inhibitors.
Clinical trials are advancing new treatments for diabetic kidney disease. Currently, 7 studies are recruiting a combined 6,900 participants across the United States. Research is being conducted by 7 organizations including Brigham and Women's Hospital, Medical College of Wisconsin, Regeneron Pharmaceuticals and 4 others.
2026 Diabetic Kidney Disease Research Landscape
As of July 2026, the diabetic kidney disease clinical trial landscape includes 7 actively recruiting studies across 32 cities in the United States. These studies are collectively seeking 6,900 participants, with an average enrollment target of 986 per study.
The research spans multiple phases of development: 3 studies are in PHASE2, 1 study is in PHASE4, 1 study is in PHASE3. The presence of Phase 3 trials indicates that some diabetic kidney disease treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 7 different organizations, including Brigham and Women's Hospital, Medical College of Wisconsin, Regeneron Pharmaceuticals, Alessandro Doria, Prokidney, and 2 others.
Geographically, diabetic kidney disease trials are most concentrated in Aurora, Colorado (3 trials); Huntsville, Alabama (2 trials); Chicago, Illinois (2 trials); Scottsdale, Arizona (1 trial); Los Angeles, California (1 trial) and 7 other cities.
Featured Diabetic Kidney Disease Studies
Highlighted recruiting studies for diabetic kidney disease, selected by enrollment size and research scope.
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
PRECIDENTD is a randomized, open label, pragmatic clinical trial designed to compare rates of the total number of cardiovascular, kidney, and death events among two alternative treatments for patients with type 2 diabetes (T2D) and either established atherosclerotic cardiovascular disease (ASCVD) or at high risk for ASCVD. To accomplish this objective, we will randomly assign 6,000 patients with e...
Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus
The overarching goal of this study is to understand facilitators and barriers to self-care, develop and refine a culturally tailored intervention to improve clinical outcomes, quality of life (QOL), and self-care behaviors in African American adults with diabetic kidney disease (DKD) experiencing health-related social needs (HRSN).
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
This study is researching experimental drugs called ALN-ANG3 and evinacumab (called "study drugs"). The study is focused on participants who have diabetic kidney disease. The aim of the study is to see how safe and effective the study drugs are. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is...
Frequently Asked Questions About Diabetic Kidney Disease Clinical Trials
Are there diabetic kidney disease clinical trials near me?
Yes, there are 7 diabetic kidney disease clinical trials currently recruiting across 32+ cities in the United States, including Aurora, Colorado; Huntsville, Alabama; Chicago, Illinois. Browse the studies above to find one at a location convenient for you.
How do I join a diabetic kidney disease clinical trial?
To join a diabetic kidney disease clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are diabetic kidney disease clinical trials free?
Yes, participation in diabetic kidney disease clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of diabetic kidney disease treatments are being studied?
Current diabetic kidney disease clinical trials are testing a range of approaches across PHASE2 (3 studies), PHASE4 (1 study), PHASE3 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 7 research organizations.
Is it safe to participate in diabetic kidney disease clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov